14 completed, 1 active not recruiting, 1 recruiting, 1 withdrawn. 10 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 8, Active not recruiting 1, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
Follow Obesity, Visceral: new trials by email Literature Review of Obesity, Visceral trials Research Report on Obesity, Visceral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NUTritional Impact of a Hypocaloric Hyperprotein Diet Before Obesity Surgery With low-calorie, high-protein diet, Without low-calorie, high-protein diet - Diet, Healthy, Obesity, Visceral | Not applicable | Recruiting | University Hospital, Rouen | 200 | 2023-10-09 | 2025-09-22 |
| Study of Lipolysis of Visceral Reserve Fat Using Tecar Therapy. Tecar Therapy - Obesity, Visceral, Obesity; Endocrine | Not applicable | Completed | CAPENERGY MEDICAL, SL | 20 | 2022-05-09 | 2025-07-17 |
| Energy Metabolism and Acute Effects of Protein Diets in Metabolically Obese Normal Weight Individuals Normal protein diet, Animal protein diet, Plant based diet - Healthy, Glucose Metabolism Disorders | Not applicable | Active not recruiting | Singapore Institute of Food and Biotechnology Innovation | 24 | 2022-02-01 | 2025-01-31 |
| Genes Variability in Obesity and Normal Body Weight Patients. MT-ATP6 mtDNA gene variability in obesity and normal body weight patients., SCD gene variability in obesity and normal body weight patients., Finding TOFI and FOTI phenotypes in participants with obesity and normal weight. - Obesity, Visceral, Obesity | Completed | Medical University of Bialystok | 116 | 2021-04-10 | 2023-03-29 | |
| Clinical Study on the Effect of a Synbiotic on Body Fat Mass synbiotic, microcrystalline cellulose - Type 2 Diabetes, Metabolic Syndrome | Not applicable | Completed | Slimbiotics GmbH | 120 | 2020-05-13 | 2022-06-01 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity No intervention - Overweight and Obesity, Overweight or Obesity | Withdrawn | ProgenaBiome | 2020-03-02 | 2025-06-05 | ||
| Investigation of the Effects of Different Levels of Obesity on the Respiratory System Obesity, Adolescent, Obesity, Morbid | Completed | Istanbul Medipol University Hospital | 100 | 2020-03-01 | 2022-02-15 | |
| Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study Alpha lipoic acid (plus full hospitalization), Placebo (full hospitalization: dietary monitoring with an adapted physical activity program) - Obesity, Obesity, Abdominal | Not applicable | Completed | Fauqué | 40 | 2018-07-02 | 2020-06-24 |
| Extreme Exercise and Energy Expenditure (4E) Study High-volume road cycling - Cardiovascular Diseases, Obesity, Visceral | Not applicable | Completed | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | 13 | 2018-06-07 | 2023-06-09 |
| Anthropometric And Body Composition Measurements Related To Osteoporosis In Geriatric Population Body mass index, waist circumference, hip circumference - Osteoporosis Senile, Obesity, Visceral | Not applicable | Completed | Istanbul Medeniyet University | 571 | 2018-01-01 | 2020-02-05 |
| The Association of Visceral Adiposity Index With Progression of Chronic Kidney Disease eGFR - Obesity, Visceral, Chronic Kidney Diseases | Completed | Uşak University | 129 | 2017-12-12 | 2020-10-19 | |
| Medical Supervised Duodenal-Enteral Feeding Treatment Nasogastroduodenal Protocol, Control, Data analysis - Obesity, Obesity, Visceral | Not applicable | Completed | BiomediKcal | 31 | 2017-08-03 | 2019-07-10 |
| Impact of Liraglutide 3.0 on Body Fat Distribution Liraglutide, Placebo - Obesity, Visceral, Cardiovascular Diseases | Phase 4 | Completed | University of Texas Southwestern Medical Center | 235 | 2017-01-01 | 2021-11-19 |
| Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program 20Lighter anti-obesity program - Obesity, Obesity, Morbid | Completed | 20Lighter | 2200 | 2016-10-27 | 2021-03-22 | |
| The "Metabolically-obese Normal-weight" Phenotype and Its Reversal by Calorie Restriction Calorie restriction - Glucose Metabolism Disorders, Obesity, Visceral | Not applicable | Completed | Singapore Institute of Food and Biotechnology Innovation | 77 | 2016-03-29 | 2018-03-13 |
| Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging [U-13C3] glycerol, Empagliflozin, Placebo (for Empagliflozin) - Obesity, Visceral | Phase 4 | Completed | University of Texas Southwestern Medical Center | 40 | 2016-03-01 | 2020-01-23 |
| Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study) Lifestyle modification program - Obesity, Visceral, Diet, Healthy | Not applicable | Completed | Laval University | 186 | 2004-03-26 | 2023-12-06 |
Obesity, Abdominal (17) · Obesity (14) · Diabetes Mellitus (3) · Metabolic Syndrome (3) · Motor Activity (3) · Obesity, Morbid (3) · Cardiovascular Diseases (2) · Diabetes Mellitus, Type 2 (2) · Glucose Metabolism Disorders (2) · Insulin Resistance (2) · Overweight (2) · Platelet Glycoprotein IV Deficiency (2) · Body Weight (1) · Dyslipidemias (1) · Endocrine System Diseases (1)
Nutrition Disorders (17) · Nutritional and Metabolic Diseases (17) · Overnutrition (17) · Pathological Conditions, Signs and Symptoms (17) · Signs and Symptoms (17) · Body Weight (16) · Overweight (15) · Metabolic Diseases (9) · Glucose Metabolism Disorders (6) · Hyperinsulinism (5) · Endocrine System Diseases (4) · Behavior (3) · Insulin Resistance (3) · Obesity (3) · Pathologic Processes (2)
Absorptiometry, Photon (1) · Adiposity (1) · Body Height (1) · Body Mass Index (1) · Caloric Restriction (1) · Diet, High-Protein (1) · Diet, Plant-Based (1) · Glycerol (1) · Helio Progress (1) · Liraglutide (1) · Phenotype (1) · Sodium Chloride (1) · Sugars (1) · Synbiotics (1) · Thioctic Acid (1)
Singapore Institute of Food and Biotechnology Innovation (2) · University of Texas Southwestern Medical Center (2) · 20Lighter (1) · BiomediKcal (1) · CAPENERGY MEDICAL, SL (1) · Fauqué (1) · Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (1) · Istanbul Medeniyet University (1) · Istanbul Medipol University Hospital (1) · Laval University (1) · Medical University of Bialystok (1) · ProgenaBiome (1) · Slimbiotics GmbH (1) · University Hospital, Rouen (1) · Uşak University (1)
Turkey (Türkiye) (3) · United States (3) · France (2) · Austria (1) · Canada (1) · Colombia (1) · Germany (1) · Poland (1) · Singapore (1) · Spain (1)
Christiane Laue, Dr. med. (1) · Faidon Magkos, PhD (1) · Ian Neeland, MD (1) · Isaac Kuzmar, Dr (1) · Jessica Barnes, PhD (1) · Parag Joshi, MD (1) · Sabine Hazan, MD (1) · Zelal Adibelli (1)
PMID 16608613, PMID 17116424, PMID 17217636, PMID 25101227, PMID 25617544, PMID 29676049, PMID 30252100, PMID 32568464, PMID 34358471, PMID 41059542
K23DK106520 (1)